Book traversal links for Abbreviations and acronyms
AlereLAM
Alere Determine™ TB LAM Ag
BD
Becton Dickinson
cfu
colony forming units
CI
confidence interval
CRS
composite reference standard
CSF
cerebrospinal fluid
DALY
disability-adjusted life year
DIAMA
Diagnostics for Multidrug Resistant Tuberculosis in Africa
DNA
deoxyribonucleic acid
DR-TB
drug-resistant tuberculosis
DST
drug susceptibility testing
ERG
External review Group
FIND
Foundation for Innovative New Diagnostics
FL-LPA
first-line line probe assay
FujiLAM
Fujifilm SILVAMP TB LAM
GDG
Guideline development group
GRADE
Grading of Recommendations Assessment, Development and Evaluation
HIV
human immunodeficiency virus
ICER
incremental cost–effectiveness ratio
LAM
lipoarabinomannan
LAMP
loop-mediated isothermal amplification
LF-LAM
lateral flow urine lipoarabinomannan assay
LMIC
low- and middle-income countries
LoD
limit of detection
LPA
line-probe assay
MDR
multidrug-resistant
MDR-TB
multidrug-resistant tuberculosis
MDR/RR-TB
multidrug-resistant tuberculosis or rifampicin-resistant tuberculosis
MRS
microbiological reference standard
Mtb
Mycobacterium tuberculosis
MTBC
Mycobacterium tuberculosis complex
NAAT
nucleic acid amplification test
NAT
nucleic acid test
NGS
next-generation sequencing
NTP
national TB programme
PCR
polymerase chain reaction
PICO
population, intervention, comparator and outcome
PLHIV
people living with HIV
PZA
pyrazinamide
QUADAS
quality assessment of diagnostic accuracy studies
QES
quality evidence synthesis
RIF
rifampicin
RNA
ribonucleic acid
RRDR
rifampicin resistance determining region
RR-TB
rifampicin-resistant tuberculosis
SL-LPA
second-line line probe assay
SRL
Supranational TB Reference Laboratory
STARD
Standards for Reporting Diagnostic Accuracy Studies
TB
tuberculosis
USA
United States of America
USAID
United States Agency for International Development
UV
ultraviolet
WGS
whole genome sequencing
WHO
World Health Organization
WTP
willingness-to-pay
XDR
extensively drug-resistant
XDR-TB
extensively drug-resistant tuberculosis